News
The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...
This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted). Shingrix is indicated for the preven ...
The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...
The syringe removes the need to reconstitute separate vials prior to administration, which simplifies the vaccine administration process for healthcare professionals, GSK said Thursday. The existing ...
New indication for Kerendia; investigational therapy shows promise for hypertension; Novolog interchangeable biosimilar gets approval; trial results for hormone-free contraceptive; Shingrix now ...
1d
GlobalData on MSNFDA approves GSK’s prefilled syringe presentation of ShingrixAdministering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.
The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...
The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.
London: GSK plc has received approval from the US Food and Drug Administration (FDA) for a prefilled syringe presentation of ...
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results